A detailed history of Met Life Investment Management, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 33,235 shares of TWST stock, worth $1.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,235
Previous 33,235 -0.0%
Holding current value
$1.59 Million
Previous $1.64 Million 8.31%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$27.95 - $53.0 $89,132 - $169,017
3,189 Added 10.61%
33,235 $1.64 Million
Q1 2024

May 14, 2024

BUY
$32.28 - $41.5 $969,884 - $1.25 Million
30,046 New
30,046 $1.03 Million
Q2 2023

Apr 29, 2024

BUY
$11.49 - $20.46 $341,138 - $607,457
29,690 New
29,690 $607,000
Q1 2023

May 09, 2024

BUY
$14.6 - $30.9 $433,474 - $917,421
29,690 New
29,690 $448 Million
Q1 2022

May 10, 2024

BUY
$38.58 - $83.27 $1.15 Million - $2.47 Million
29,690 New
29,690 $1.47 Million
Q1 2022

Mar 22, 2023

BUY
$38.58 - $83.27 $513,422 - $1.11 Million
13,308 Added 81.24%
29,690 $1.47 Million
Q1 2022

May 12, 2022

BUY
$38.58 - $83.27 $513,422 - $1.11 Million
13,308 Added 81.24%
29,690 $1.47 Million
Q4 2021

Jun 21, 2023

SELL
$75.47 - $135.88 $1 Million - $1.81 Million
-13,308 Reduced 44.82%
16,382 $1.27 Million
Q3 2021

May 17, 2024

SELL
$95.64 - $131.48 $101,378 - $139,368
-1,060 Reduced 6.08%
16,382 $1.75 Million
Q3 2021

Jun 21, 2023

SELL
$95.64 - $131.48 $1.27 Million - $1.75 Million
-13,308 Reduced 44.82%
16,382 $1.75 Million
Q3 2021

Mar 22, 2023

SELL
$95.64 - $131.48 $101,378 - $139,368
-1,060 Reduced 6.08%
16,382 $1.75 Million
Q3 2021

Nov 15, 2021

SELL
$95.64 - $131.48 $101,378 - $139,368
-1,060 Reduced 6.08%
16,382 $1.75 Million
Q2 2021

Jun 21, 2023

SELL
$88.13 - $142.06 $1.08 Million - $1.74 Million
-12,248 Reduced 41.25%
17,442 $2.32 Million
Q1 2021

May 17, 2024

SELL
$105.48 - $207.97 $1.33 Million - $2.62 Million
-12,604 Reduced 41.95%
17,442 $2.16 Million
Q1 2021

Jun 26, 2023

SELL
$105.48 - $207.97 $1.29 Million - $2.55 Million
-12,248 Reduced 41.25%
17,442 $2.16 Billion
Q1 2021

Mar 22, 2023

BUY
$105.48 - $207.97 $421,603 - $831,256
3,997 Added 29.73%
17,442 $2.16 Million
Q1 2021

May 14, 2021

BUY
$105.48 - $207.97 $421,603 - $831,256
3,997 Added 29.73%
17,442 $2.16 Million
Q4 2020

Jun 22, 2023

SELL
$76.64 - $167.89 $1.25 Million - $2.73 Million
-16,245 Reduced 54.72%
13,445 $1.9 Million
Q3 2020

Jun 26, 2023

SELL
$45.46 - $78.79 $738,497 - $1.28 Million
-16,245 Reduced 54.72%
13,445 $1.02 Million
Q2 2020

May 24, 2024

SELL
$26.4 - $45.3 $438,266 - $752,025
-16,601 Reduced 55.25%
13,445 $609 Million
Q2 2020

Jun 26, 2023

SELL
$26.4 - $45.3 $428,868 - $735,898
-16,245 Reduced 54.72%
13,445 $609,000
Q2 2020

Mar 22, 2023

BUY
$26.4 - $45.3 $47,863 - $82,128
1,813 Added 15.59%
13,445 $609,000
Q2 2020

Aug 14, 2020

BUY
$26.4 - $45.3 $47,863 - $82,128
1,813 Added 15.59%
13,445 $609,000
Q1 2020

Jul 12, 2023

SELL
$19.71 - $35.15 $355,923 - $634,738
-18,058 Reduced 60.82%
11,632 $355,000
Q1 2020

Mar 22, 2023

BUY
$19.71 - $35.15 $27,396 - $48,858
1,390 Added 13.57%
11,632 $355,000
Q1 2020

May 15, 2020

BUY
$19.71 - $35.15 $27,396 - $48,858
1,390 Added 13.57%
11,632 $356,000
Q4 2019

Jul 12, 2023

SELL
$21.0 - $26.48 $408,408 - $514,983
-19,448 Reduced 65.5%
10,242 $215,000
Q3 2019

Jul 12, 2023

SELL
$23.72 - $33.99 $461,306 - $661,037
-19,448 Reduced 65.5%
10,242 $244,000
Q3 2019

Mar 22, 2023

SELL
$23.72 - $33.99 $461,306 - $661,037
-19,448 Reduced 65.5%
10,242 $244,000
Q3 2019

Nov 14, 2019

BUY
$23.72 - $33.99 $242,940 - $348,125
10,242 New
10,242 $245,000
Q2 2019

Jul 12, 2023

SELL
$21.74 - $33.2 $422,799 - $645,673
-19,448 Reduced 65.5%
10,242 $297 Million

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.7B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.